Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Second Round Of Cardinal Restructuring To Begin In '06

This article was originally published in The Pink Sheet Daily

Executive Summary

Cardinal Health expects the second phase of its restructuring initiative to generate $300 mil. in savings by fiscal 2008, the wholesaler reported Aug. 5

You may also be interested in...



Cardinal Reorganization Creates Single Supply Chain Unit

The business will combine Cardinal's pharmaceutical distribution, medical products distribution and nuclear services businesses.

Cardinal Reorganization Creates Single Supply Chain Unit

The business will combine Cardinal's pharmaceutical distribution, medical products distribution and nuclear services businesses.

Cardinal Fee-For-Service Distribution Margins Lower Than Anticipated

Wholesaler remains optimistic that manufacturers' distribution fees will rise over time due to "built-in escalators" in existing contracts and potential to increase fees during contract renewal.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS062838

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel